.August 20, 2024 10:20 AM

Medtronic (NYSE:MDT) reported Q1 earnings that beat analyst expectations, with EPS of $1.23 and revenue of $7.9 billion. The adjusted gross margin was 65.9%, slightly lower than last year but higher than predicted. Operating margin was 24.4%, in line with expectations. The company raised its fiscal 2025 non-GAAP EPS guidance to $5.42-$5.50, reflecting a 4%-6% growth. Organic revenue growth forecast was increased to 4.5%-5% from 4%-5%.